Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-Transplant Complication

Late hemorrhagic cystitis after reduced-intensity hematopoietic stem cell transplantation (RIST)

Bone Marrow Transplantation volume 32, pages 1089–1095 (2003)Cite this article

Summary:

We reviewed medical records of 256 patients to investigate the frequency and characteristics of hemorrhagic cystitis (HC) associated with reduced-intensity stem cell transplantation (RIST) as opposed to conventional stem cell transplantation (CST); 137 patients underwent CST and 119 RIST. Diagnosis of HC was made based on two or more episodes of sterile, macroscopic hematuria with normal coagulation profiles, without any evidence of renal stones or genitourinary malignancy. Actuarial frequency of HC development in RIST group was 7.6% (9/119), which gave a cumulative annual incidence of 11.7%. In CST group, 13 of 137 patients (9.5%) developed HC, giving an estimated annual incidence of 9.7%. The probability of developing HC was similar between the two groups (P=0.77). The viral etiologies of HC, adenovirus (n=12) and BK virus (n=2), were documented in eight patients after RIST and in six after CST. HC was milder and of a shorter duration, with less blood transfusion requirements, in RIST group than in CST group. A multivariate analysis revealed that HC was associated with antiadenovirus antibody positivity in the recipients, total dose of busulfan, and chronic GVHD. Although HC following RIST is less severe than that following CST, it is still a significant problem.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

Article 15 July 2021

John A. Kellum, Paola Romagnani, … Hans-Joachim Anders

References

  1. Giralt S, Estey E, Albitar M et al. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy. Blood 1997; 89: 4531–4536.

    CAS  PubMed  Google Scholar 

  2. Slavin S, Nagler A, Naparstek E et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cyto-reduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 1998; 91: 756–763.

    CAS  PubMed  Google Scholar 

  3. Childs R, Chernoff A, Contentin N et al. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem cell transplantation. N Engl J Med 2000; 343: 750–758.

    Article  CAS  PubMed  Google Scholar 

  4. Khouri IF, Keating M, Korbling M et al. Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies. J Clin Oncol 1998; 16: 2817–2824.

    Article  CAS  PubMed  Google Scholar 

  5. Saito T, Kanda Y, Kami M et al. Therapeutic potential of a reduced-intensity preparative regimen for allogeneic transplantation with cladribine, busulfan, and antithymocyte globulin against advanced/refractory acute leukemia/lymphoma. Clin Cancer Res 2002; 8: 1014–1020.

    CAS  PubMed  Google Scholar 

  6. McSweeney PA, Niederwieser D, Shizuru JA et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood 2001; 97: 3390–3400.

    Article  CAS  PubMed  Google Scholar 

  7. Sencer SF, Haake RJ, Weisdorf DJ . Hemorrhagic cystitis after bone marrow transplantation. Risk factors and complications. Transplantation 1993; 56: 875–879.

    Article  CAS  PubMed  Google Scholar 

  8. Santos GW, Tutschka PJ, Brookmeyer R et al. Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide. N Engl J Med 1983; 309: 1347–1353.

    Article  CAS  PubMed  Google Scholar 

  9. Brugieres L, Hartmann O, Travagli JP et al. Hemorrhagic cystitis following high-dose chemotherapy and bone marrow transplantation in children with malignancies: incidence, clinical course, and outcome. J Clin Oncol 1989; 7: 194–199.

    Article  CAS  PubMed  Google Scholar 

  10. Bedi A, Miller CB, Hanson JL et al. Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation. J Clin Oncol 1995; 13: 1103–1109.

    Article  CAS  PubMed  Google Scholar 

  11. Yang CC, Hurd DD, Case LD et al. Hemorrhagic cystitis in bone marrow transplantation. Urology 1994; 44: 322–328.

    Article  CAS  PubMed  Google Scholar 

  12. Haselberger MB, Schwinghammer TL . Efficacy of mesna for prevention of hemorrhagic cystitis after high-dose cyclophos-phamide therapy. Ann Pharmacother 1995; 29: 918–921.

    Article  CAS  PubMed  Google Scholar 

  13. Thomas AE, Patterson J, Prentice HG et al. Haemorrhagic cystitis in bone marrow transplantation patients: possible increased risk associated with prior busulphan therapy. Bone Marrow Transplant 1987; 1: 347–355.

    CAS  PubMed  Google Scholar 

  14. Ringden O, Labopin M, Tura S et al. A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Br J Haematol 1996; 93: 637–645.

    Article  CAS  PubMed  Google Scholar 

  15. Arthur RR, Shah KV, Baust SJ et al. Association of BK viruria with hemorrhagic cystitis in recipients of bone marrow transplants. N Engl J Med 1986; 315: 230–234.

    Article  CAS  PubMed  Google Scholar 

  16. Ost L, Lonnqvist B, Eriksson L et al. Hemorrhagic cystitis – a manifestation of graft versus host disease? Bone Marrow Transplant 1987; 2: 19–25.

    CAS  PubMed  Google Scholar 

  17. Appelbaum FR, Barrall J, Storb R et al. Bone marrow transplantation for patients with myelodysplasia. Pretreatment variables and outcome. Ann Intern Med 1990; 112: 590–597.

    Article  CAS  PubMed  Google Scholar 

  18. Tutschka PJ, Copelan EA, Klein JP . Bone marrow transplantation for leukemia following a new busulfan and cyclophos-phamide regimen. Blood 1987; 70: 1382–1388.

    CAS  PubMed  Google Scholar 

  19. Niiya H, Kanda Y, Saito T et al. Early full donor myeloid chimerism after reduced-intensity stem cell transplantation using a combination of fludarabine and busulfan. Haemato-logica 2001; 86: 1071–1074.

    CAS  Google Scholar 

  20. Przepiorka D, Weisdorf D, Martin P et al. 1994 consensus conference on acute GVHD grading. Bone Marrow Transplant 1995; 15: 825–828.

    CAS  PubMed  Google Scholar 

  21. Sullivan KM, Agura E, Anasetti C et al. Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol 1991; 28: 250–259.

    CAS  PubMed  Google Scholar 

  22. Kanda Y, Mineishi S, Nakai K et al. Frequent detection of rising cytomegalovirus antigenemia after allogeneic stem cell transplantation following a regimen containing antithymocyte globulin. Blood 2001; 97: 3676–3677.

    Article  CAS  PubMed  Google Scholar 

  23. Kanda Y, Mineishi S, Saito T et al. Response-oriented preemptive therapy against cytomegalovirus disease with low-dose ganciclovir: a prospective evaluation. Transplantation 2002; 73: 568–572.

    Article  CAS  PubMed  Google Scholar 

  24. Pizzo PA . Management of fever in patients with cancer and treatment-induced neutropenia. N Engl J Med 1993; 328: 1323–1332.

    Article  CAS  PubMed  Google Scholar 

  25. Akiyama H, Kurosu T, Sakashita C et al. Adenovirus is a key pathogen in hemorrhagic cystitis associated with bone marrow transplantation. Clin Infect Dis 2001; 32: 1325–1330.

    Article  CAS  PubMed  Google Scholar 

  26. Miyamura K, Takeyama K, Kojima S et al. Hemorrhagic cystitis associated with urinary excretion of adenovirus type 11 following allogeneic bone marrow transplantation. Bone Marrow Transplant 1989; 4: 533–535.

    CAS  PubMed  Google Scholar 

  27. Childs R, Sanchez C, Engler H et al. High incidence of adeno- and polyomavirus-induced hemorrhagic cystitis in bone marrow allotransplantation for hematological malignancy following T cell depletion and cyclosporine. Bone Marrow Transplant 1998; 22: 889–893.

    Article  CAS  PubMed  Google Scholar 

  28. Kohno A, Takeyama K, Narabayashi M et al. Hemorrhagic cystitis associated with allogeneic and autologous bone marrow transplantation for malignant neoplasms in adults. Jpn J Clin Oncol 1993; 23: 46–52.

    CAS  PubMed  Google Scholar 

  29. Seber A, Shu XO, Defor T et al. Risk factors for severe hemorrhagic cystitis following BMT. Bone Marrow Transplant 1999; 23: 35–40.

    Article  CAS  PubMed  Google Scholar 

  30. Droller MJ, Saral R, Santos G . Prevention of cyclophos-phamide-induced hemorrhagic cystitis. Urology 1982; 20: 256–258.

    Article  CAS  PubMed  Google Scholar 

  31. Kondo M, Kojima S, Kato K et al. Late-onset hemorrhagic cystitis after hematopoietic stem cell transplantation in children. Bone Marrow Transplant 1998; 22: 995–998.

    Article  CAS  PubMed  Google Scholar 

  32. Runde V, Ross S, Trenschel R et al. Adenoviral infection after allogeneic stem cell transplantation (SCT): report on 130 patients from a single SCT unit involved in a prospective multi center surveillance study. Bone Marrow Transplant 2001; 28: 51–57.

    Article  CAS  PubMed  Google Scholar 

  33. Shields AF, Hackman RC, Fife KH et al. Adenovirus infections in patients undergoing bone-marrow transplantation. N Engl J Med 1985; 312: 529–533.

    Article  CAS  PubMed  Google Scholar 

  34. Russell SJ, Vowels MR, Vale T . Haemorrhagic cystitis in paediatric bone marrow transplant patients: an association with infective agents, GVHD and prior cyclophosphamide. Bone Marrow Transplant 1994; 13: 533–539.

    CAS  PubMed  Google Scholar 

  35. Trotman J, Nivison-Smith I, Dodds A . Haemorrhagic cystitis: incidence and risk factors in a transplant population using hyperhydration. Bone Marrow Transplant 1999; 23: 797–801.

    Article  CAS  PubMed  Google Scholar 

  36. Bacigalupo A, Lamparelli T, Bruzzi P et al. Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO). Blood 2001; 98: 2942–2947.

    Article  CAS  PubMed  Google Scholar 

  37. Atkinson K, Biggs J, Noble G et al. Preparative regimens for marrow transplantation containing busulphan are associated with haemorrhagic cystitis and hepatic veno-occlusive disease but a short duration of leucopenia and little oro-pharyngeal mucositis. Bone Marrow Transplant 1987; 2: 385–394.

    CAS  PubMed  Google Scholar 

  38. Millard RJ . Busulfan-induced hemorrhagic cystitis. Urology 1981; 18: 143–144.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hematopoietic Stem Cell Transplantation Unit, National Cancer Center Hospital, Tokyo, Japan

    R Yamamoto, M Kami, T Hamaki, A Saito, N Murasgihe, A Hori, S-W Kim, A Makimoto, R Tanosaki, S Mori, Y Heike & Y Takaue

  2. Department of Hematology, Toranomon Hospital, Tokyo, Japan

    E Kusumi, K Yuji, J Ueyama, S Miyakoshi, S Morinaga, S Taniguchi & Y Mutou

  3. Department of Hematology and Rheumatology, JR Tokyo General Hospital, Tokyo, Japan

    S Masuo

Authors
  1. R Yamamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E Kusumi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M Kami
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. K Yuji
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. T Hamaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A Saito
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. N Murasgihe
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. A Hori
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. S-W Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. A Makimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. J Ueyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. R Tanosaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. S Miyakoshi
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. S Mori
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. S Morinaga
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Y Heike
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. S Taniguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. S Masuo
    View author publications

    You can also search for this author in PubMed Google Scholar

  19. Y Takaue
    View author publications

    You can also search for this author in PubMed Google Scholar

  20. Y Mutou
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M Kami.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yamamoto, R., Kusumi, E., Kami, M. et al. Late hemorrhagic cystitis after reduced-intensity hematopoietic stem cell transplantation (RIST). Bone Marrow Transplant 32, 1089–1095 (2003). https://doi.org/10.1038/sj.bmt.1704261

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1704261

Keywords

This article is cited by

Search

Advanced search

Quick links